RUNX1 and leukemia: Possible biological explanations for that involve the persistence of RUNX1/RUNX1T1 in pre-leukemic clones [13,17], as well as the development of an immunosurveillance effective in preventing disease reoccurrence by the autologous immune system or by Graft-vs-Leukemia effects after allo-HSCT.